Mar 20, 2024
Press communication Lund, Sweden, March 20, 2024 This is a translation of the Swedish press release published 2024-03-20 The initial months of 2024 continue with intensive work and positive progress for Neola Medical in preparation for upcoming studies for market...
Mar 14, 2024
CEO Hanna Sjöström continues her work of establishing international contacts with key opinion leaders and expanding the company’s network as part of the preparatory work for the launch of Neola® in the USA. Recently, CEO Hanna Sjöström visited the neonatal...
Mar 13, 2024
Almost all life science companies want to break into the American market. What are the economic, strategic, and political reasons behind this? Hanna Sjöström, CEO of Neola Medical, discusses both what attracts in the USA and what decisions the government would need to...
Mar 11, 2024
Results from a study conducted by world-leading researchers in optical spectroscopy from the Tyndall National Institute, Cork, Ireland, in collaboration with Neola Medical, have been published in the Journal of Biomedical Optics. The purpose of the study was to...
Mar 5, 2024
Lund-based Neola Medical continues to advance towards clinical studies with its lung monitoring system. The company is now starting a usability study – an important part of the process to be able to launch the product in the US. BioStock spoke to CEO Hanna Sjöström to...
Feb 29, 2024
Press communication Lund, Sweden, February 29 This is a translation of the Swedish press release published 2024-02-29, 07.00 CET Neola Medical AB (publ) will commence a Human Factors Validation Study in March 2024 with Neola®, the company’s medical device for...
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPersonal Data Policy
